Quiénes somos
La propiedad industrial e intelectual es nuestra pasión.
Las ideas y la innovación son nuestro motor.
Trabajamos incansablemente para salvaguardarlos y ayudar a nuestros clientes a innovar y ser motor de cambio.
En HOYNG ROKH MONEGIER sabemos que nuestros clientes precisan de un abogado especialista en propiedad industrial e intelectual que conozca su industria, que sea franco, directo y capaz de cumplir. Pase lo que pase.
Contamos con un equipo en Europa de más de un centenar de profesionales de la propiedad industrial e intelectual. En la firme creencia de que la calidad jurídica no puede quedar comprometida, decidimos dedicar nuestra práctica exclusivamente a la propiedad industrial e intelectual y a materias regulatorias conexas. Contamos también con la experiencia y con los conocimientos técnicos necesarios para enfrentarnos a los desafíos tecnológicos que frecuentemente protagonizan los conflictos en materia de propiedad industrial. Nuestra experiencia y nuestra mentalidad pionera se alían en la representación de asuntos de gran envergadura que en muchos casos son transfronterizos.
HOYNG ROKH MONEGIER es la firma de referencia en materia de propiedad industrial e intelectual en Europa.
Últimas Noticias
UPC Unfiltered, by Willem Hoyng – UPC decisions week 52, 2025
Below, Prof. Willem Hoyng provides his unfiltered views on the decisions that were published on the website of the Unified Patent Court (“UPC”) last week. His comments offer a unique insight into the UPC’s case law, as he chairs the Advisory Board of the UPC and participated in drafting the Rules of Procedure of the UPC.
Interested in more of this? Stay tuned and subscribe here for weekly updates.
On the go, multi-tasking or just prefer to listen? “Willem Hoyng’s UPC Unfiltered AI Podcast” – your weekly, AI-generated podcast discussing Willem Hoyng’s commentary on UPC case law of last week, offers a convenient alternative. Listen on Spotify or Apple Podcasts.
UPC Unfiltered, by Willem Hoyng – UPC decisions week 51, 2025
Below, Prof. Willem Hoyng provides his unfiltered views on the decisions that were published on the website of the Unified Patent Court (“UPC”) last week. His comments offer a unique insight into the UPC’s case law, as he chairs the Advisory Board of the UPC and participated in drafting the Rules of Procedure of the UPC.
Imminent Infringement and the Bolar Exemption before the UPC
When can a patent owner obtain provisional relief before the alleged infringer has actually placed any products on the market? According to the Unified Patent Court Agreement (“UPCA”), injunctive measures may be ordered to prevent an imminent infringement (art. 62.1). In its first life-sciences cases, the UPC has developed a legal test for imminent infringement based on whether the alleged infringer has already set the stage for the infringement to occur. This standard, confirmed by the UPC Court of Appeal in Boehringer Ingelheim v. Zentiva (UPC_CoA_446/2025), has important implications for life sciences and interacts with regulatory safe harbors such as the Bolar exemption, particularly in light of proposed EU legislation to expand that exemption, the draft EU Pharmaceutical Directive )COM (2023) 192 final, 2023/0123 (COD)).
This post examines the UPC’s imminent infringement doctrine, how it has been applied and its interplay with the Bolar exemption.